Given that the hyperactivation of the PI3K/AKT/mTOR pathway is an important leading cause of numerous solid tumors and overgrowth syndromes, targeting this pathway signaling is an effective therapy for these disorders. Here, PIK3CA is linked to overgrowth syndrome.